0.75Open0.75Pre Close0 Volume29 Open Interest17.50Strike Price0.00Turnover71.98%IV3.12%PremiumDec 20, 2024Expiry Date0.21Intrinsic Value100Multiplier6DDays to Expiry0.54Extrinsic Value100Contract SizeAmericanOptions Type-0.5303Delta0.2472Gamma23.05Leverage Ratio-0.0536Theta-0.0015Rho-12.22Eff Leverage0.0089Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet